- Home
- SLNO vs ULCC Comparison
SLNO vs ULCC Comparison
Compare SLNO & ULCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLNO
- ULCC
- Stock Information
- Founded
- SLNO 1999
- ULCC 1994
- Country
- SLNO United States
- ULCC United States
- Employees
- SLNO N/A
- ULCC N/A
- Industry
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ULCC Air Freight/Delivery Services
- Sector
- SLNO Health Care
- ULCC Consumer Discretionary
- Exchange
- SLNO Nasdaq
- ULCC Nasdaq
- Market Cap
- SLNO 1.9B
- ULCC 1.5B
- IPO Year
- SLNO 2014
- ULCC 2021
- Fundamental
- Price
- SLNO $54.63
- ULCC $5.55
- Analyst Decision
- SLNO Strong Buy
- ULCC Hold
- Analyst Count
- SLNO 7
- ULCC 11
- Target Price
- SLNO $69.86
- ULCC $6.35
- AVG Volume (30 Days)
- SLNO 504.7K
- ULCC 2.6M
- Earning Date
- SLNO 11-06-2024
- ULCC 10-29-2024
- Dividend Yield
- SLNO N/A
- ULCC N/A
- EPS Growth
- SLNO N/A
- ULCC N/A
- EPS
- SLNO N/A
- ULCC N/A
- Revenue
- SLNO N/A
- ULCC $3,664,000,000.00
- Revenue This Year
- SLNO N/A
- ULCC $6.19
- Revenue Next Year
- SLNO N/A
- ULCC $14.64
- P/E Ratio
- SLNO N/A
- ULCC N/A
- Revenue Growth
- SLNO N/A
- ULCC 1.66
- 52 Week Low
- SLNO $26.38
- ULCC $2.79
- 52 Week High
- SLNO $59.75
- ULCC $8.33
- Technical
- Relative Strength Index (RSI)
- SLNO 51.30
- ULCC 41.46
- Support Level
- SLNO $50.69
- ULCC $5.12
- Resistance Level
- SLNO $59.75
- ULCC $6.96
- Average True Range (ATR)
- SLNO 2.47
- ULCC 0.42
- MACD
- SLNO -0.48
- ULCC -0.17
- Stochastic Oscillator
- SLNO 43.47
- ULCC 20.57
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.
About ULCC Frontier Group Holdings Inc.
Frontier Group Holdings Inc is an ultra-low-cost carrier whose business is focused on Low Fares Done Right. The company owns a fleet of 120 Airbus single-aisle aircraft, consisting of 13 A320ceos, 82 A320neos, 21 A321ceos and 4 A321neos. The use of these aircraft, their seating configuration, weight-saving tactics, and baggage process have all contributed to the ability to continue to be the fuel-efficient of all the U.S. The Company is managed as a single business unit that provides air transportation for passengers.